Targeted treatment for activated phosphoinositide 3-kinase delta syndrome, CTLA-4 insufficiency, and STAT1 gain-of-function.

Ann Allergy Asthma Immunol

Department of Pediatrics, K. Hovnanian Children's Hospital, Jersey Shore University Medical Center, Neptune, New Jersey; Hackensack Meridian School of Medicine, Nutley, New Jersey.

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anai.2024.11.018DOI Listing

Publication Analysis

Top Keywords

targeted treatment
4
treatment activated
4
activated phosphoinositide
4
phosphoinositide 3-kinase
4
3-kinase delta
4
delta syndrome
4
syndrome ctla-4
4
ctla-4 insufficiency
4
insufficiency stat1
4
stat1 gain-of-function
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!